JPMorgan Q3 IB-fee growth (forecast)
Mid-to-high teens
Doug Petno at Barclays conference, Sep 15, 2026
JPMorgan Q3 trading revenue (forecast)
Mid-to-high teens
Doug Petno at Barclays conference, Sep 15, 2026
Bank of America Q3 IB fees (forecast)
Down 10%+
$1.6B–$1.8B vs. $2B year-ago; Brian Moynihan at Barclays, Sep 14, 2026
Bank of America Q3 trading revenue (forecast)
Relatively flat
Brian Moynihan at Barclays conference, Sep 14, 2026
Bank of America stock move (Sep 15)
−5.14%
$59.47, biggest single-day drop since April 2025
JPMorgan Q2 net income (reported)
$21.2B
$7.70/share, record; July 14, 2026 earnings release
Two CEOs, Same Stage, Opposite Calls
On consecutive afternoons at the Barclays Global Financial Services Conference in New York, the CEOs and senior leadership of the two largest US banks gave investors diametrically opposite views of the capital-markets business heading into Q3 2026. Bank of America Chair and CEO Brian Moynihan told the room on Monday, September 14 that investment-banking fees would fall more than 10% from a year earlier, projecting $1.6B–$1.8B for the quarter, and that sales-and-trading revenue would be \"relatively flat.\" The next day, JPMorgan co-president Doug Petno forecast mid-to-high-teens percentage growth in both investment-banking fees and trading revenue, telling investors deal activity was \"quite robust\" with no meaningful economic deterioration in sight.
The split crystallized into a stock trade within hours. Bank of America fell 5.14% on September 15 to $59.47 — its largest single-day drop since April 2025 — while Citigroup slipped 1.9% in sympathy. JPMorgan, which had led the cohort with a record Q2, closed the same session down just 1.62% at $344.45, having given back less ground than peers on the same news day. The market was pricing the divergence: when the head of one of the two biggest US franchises tells you the cycle has rolled over, while the head of the other tells you Q3 will \"shine,\" the implication is that Q2's strong-everywhere tape is becoming a select-names story.
The Q2 Baseline That Makes the Split Plausible
Both banks came into the September conferences having just printed blockbuster Q2 2026 numbers — released July 14 — which is why their Q3 forecasts are landing so differently. JPMorgan's Commercial & Investment Bank generated $24.9B in managed net revenue, up 27% year over year, with investment-banking fees of $3.3B (+30%) and Markets revenue of $12.1B (+35%). Inside that, Equity Markets revenue hit $6.0B, up 86% from a year earlier — a record — while Fixed Income Markets grew a more modest 6%. The bank was lead active bookrunner on Alphabet's $85B equity offering and co-adviser on NextEra Energy's $67B merger with Dominion Energy. CIB net income was $9.7B, up 46%.
Bank of America also had a strong Q2 — total IB fees of $2.1B (+50% year over year) and Global Markets revenue of $8.0B (+33%), with equities trading of $3.6B (+70%) and FICC of $3.5B (+9%). But the Q2 base was lower than JPM's to begin with: BAC is a much larger consumer-and-deposit franchise with proportionally less IB and trading exposure, and its equities-trading record, while strong in percentage terms, was half of JPM's in absolute dollars.
| Metric (Q2 2026) | JPMorgan | Bank of America | Source |
|---|---|---|---|
| Investment-banking fees | $3.3B (+30% YoY) | $2.1B (+50% YoY) | Q2 2026 earnings releases |
| Markets / sales-and-trading revenue | $12.1B (+35%) | $7.1B S&T / $8.0B total (+33%) | Q2 2026 earnings releases |
| Equities trading | $6.0B (+86%) | $3.6B (+70%) | Q2 2026 earnings releases |
| Fixed-income trading | $6.1B (+6%) | $3.5B FICC (+9%) | Q2 2026 earnings releases |
| Global IB wallet share | 9.3% (#1, YTD) | n/a | JPM Q2 2026 press release |
| Total IB fees rank | #1 | Below top tier | Dealogic via Reuters |
Why Petno Sees 'Shine' and Moynihan Sees Flat
The drivers Petno and Moynihan each cited at Barclays explain most of the gap. Petno pointed to four specific engines: M&A activity, equity underwriting, fixed-income trading, and equities activity, with no sign of \"meaningful economic deterioration.\" JPMorgan's wallet-share data backs that up — the bank ranked #1 globally in IB fees YTD with 9.3% wallet share, ahead of Goldman Sachs, and its Q2 IB pipeline produced the Alphabet and NextEra–Dominion mandates, both bellwether transactions. Petno was asked directly at the conference about competitors' weaker commentary and replied, per the Wall Street Journal: \"Not much that I want to say in this room.\" That restraint is itself a tell — JPM does not need to talk down peers to defend its own outlook.
Bank of America's Moynihan, by contrast, framed Q3 as a pull-forward sequel. He told Barclays the capital-markets business is \"active but pacing easing vs prior quarter,\" and he explicitly cited Dealogic data showing industry-wide IB fees running roughly 10% lower than a year ago, with BofA \"down probably a bit more than that.\" He was also unusually candid about which pockets are cooling — financing activity slowed from Q2, with the international business and Asia prime brokerage especially weak — and described sales-and-trading as \"one of the better third quarters historically, but roughly flat YoY.\" That phrasing matters. Q32026 will print as one of the better Q3s on record only because the Q3 2025 comparable is weak; compared with Q2 2026, BAC is guiding to a meaningful step-down.
Q3 2026 outlook — percentage change vs. year-ago quarter
Forecast as stated at the Barclays Global Financial Services Conference, September 14–15, 2026
Unit: % YoY (forecast midpoint)
JPM IB fees
Mid-to-high teens (Petno)
15
JPM trading
Mid-to-high teens (Petno)
15
BAC IB fees
Down 10%+ (Moynihan)
-12
BAC trading
Relatively flat (Moynihan)
0
The Rest of the Cohort: Who Has to Pick a Side
JPMorgan and Bank of America aren't the only banks that will set the Q3 tone. The cohort that reported July 14 split cleanly into three camps on the IB line. Goldman Sachs booked IB fees of $3.4B, up 55% year over year, the largest absolute jump in the group and consistent with the bulge-bracket narrative Petno is selling; GS has not yet publicly guided for Q3 but historically runs the highest beta to capital-markets cycles. Citigroup printed IB fees of $1.55B (+44%), with equities trading up 45% and ECM up 91% in the first half — but the stock fell5.3% post-print because expense discipline, not deal flow, drove the narrative.
Morgan Stanley leans more on wealth and asset management, with Q2 revenue of $34.5B and net income of $5.58B; its capital-markets arm still swung with the cycle, but its earnings stream is more diversified than BAC's or even JPM's. Wells Fargo has the least exposure of the major US banks to IB and trading revenue — its Q2 beat was driven by NII, credit, and expense control, not by capital-markets flow. Both names therefore sit between the JPM and BAC poles: too deal-exposed to ignore a slowdown, too diversified to be punished like BAC.
The investor question now is whether Moynihan's read — \"capital markets active but pacing easing\" — is the industry read or a BofA-specific read. Moynihan explicitly said the industry (per Dealogic) is \"down about 10%,\" and BofA is down a bit more. If Petno's JPM-specific view (mid-to-high teens) is right, JPM is taking share from BAC, Citigroup, and others — a thesis consistent with JPM's 9.3% global wallet share running ahead of any US peer in2026. If Moynihan's industry view is right, JPM's Q3 number will undershoot its own guidance, and the bull case collapses into the same air pocket BAC just warned about.
The Pair Trade — and What Could Break It
On the facts in front of the market today, the cleanest expression of the divergence is long JPMorgan, short Bank of America. JPM Q3 IB +mid-to-high teens versus BAC Q3 IB −10%+ implies a >25-point swing on a single revenue line that, on Q2 levels, is roughly $1.2B of additional Q3 IB revenue for JPM versus BAC. JPM Q3 trading +mid-to-high teens versus BAC Q3 trading flat implies another $1B-plus of incremental trading revenue at JPM relative to BAC. Combined, the capital-markets gap alone could be $2B+ of revenue in Q3, or roughly 2% of JPM's annual revenue base versus 4% of BAC's.
Valuation reinforces the asymmetry. JPM trades at 15.0x trailing earnings with a $923B market cap and an analyst target of $376 — implying roughly 9% upside — and is rated Buy/Strong-Buy by 13 of 24 covering analysts. BAC trades at 14.5x trailing earnings with a $422B market cap and a $69 target, about 16% upside, and is rated Buy/Strong-Buy by 20 of 24. The market is giving BAC more upside even before the IB shortfall is realized; if JPM hits its Q3 numbers and BAC misses, that gap closes fast.
| Bank | Price | Mkt Cap | TTM P/E | Fwd P/E | Analyst Target | Upside |
|---|---|---|---|---|---|---|
| JPMorgan (JPM) | $344.45 | $923B | 15.0x | 14.2x | $376 | 9% |
| Bank of America (BAC) | $59.47 | $422B | 14.5x | 12.0x | $69 | 16% |
| Goldman Sachs (GS) | n/a | n/a | n/a | n/a | n/a | n/a |
| Citigroup (C) | n/a | n/a | n/a | n/a | n/a | n/a |
| Morgan Stanley (MS) | n/a | n/a | n/a | n/a | n/a | n/a |
| Wells Fargo (WFC) | n/a | n/a | n/a | n/a | n/a | n/a |
Horizons — Short-Term Catalyst vs. One- to Three-Year Setup
The catalyst calendar is unusually compressed. JPMorgan reports Q3 2026 earnings on October 13, the first of the cohort — a four-week window in which the Petno guide either prints or doesn't, and the BAC guide either holds or surprises. Bank of America, Citigroup, Goldman Sachs, Morgan Stanley, and Wells Fargo all report the same week, so the trade arbitrages itself in roughly five trading days. Investors who want the Petno thesis priced in have to act now; those who want to wait for JPM's actual print are betting BAC's guide is the right read on the industry.
Over the 1–3 year horizon, the setup is less about Q3 and more about wallet-share migration. JPM's #1 global IB ranking with 9.3% wallet share, combined with its $5.0T balance sheet, $1.5T Security and Resiliency Initiative, and the new co-president structure (Petno and Troy Rohrbaugh, named June 2026), positions it to keep taking share in any quarter where the capital-markets pie is even flat. Moynihan's BofA is structurally a deposit-and-consumer bank that happens to do capital markets; that franchise works when rates are stable and consumers spend — and on his own Barclays numbers it is working ($2T deposits, normalized credit, +14 bps NII yield). But it makes BofA a relative loser whenever the capital-markets line of the income statement matters most, which is exactly the line of business that just rolled.
How to play the JPM-up, BofA-down divergence
- Q3 IB fees and trading guided mid-to-high teens by Doug Petno at Barclays on Sep 15, against BAC's −10% IB and flat trading outlook.
- Q2 set a high bar with $21.2B net income, $3.3B IB fees (+30% YoY), and a record $6.0B equity-markets print (+86% YoY); hitting the Q3 guide would extend a record run.
- #1 global IB wallet share at 9.3% means any industry slowdown hits JPM less than peers; share gains from BofA are a distinct possibility in a flat-Q3 scenario.
- Pair trade entry: long JPM, short BAC, with the thesis arbitraged on October 13 when JPM reports Q3 first.
- CEO Moynihan projected Q3 IB fees of $1.6B–$1.8B at Barclays on Sep 14, a 10%+ drop from a year ago and a sharp step-down from Q2's $2.1B (+50%).
- Q3 sales-and-trading guided \"relatively flat\" vs. year-ago; international and Asia prime brokerage cited as specific pockets of weakness.
- Stock fell 5.14% to $59.47 on Sep 15 — its biggest single-day drop since April 2025 — pricing in the roll-over but still carrying 16% upside to a $69 analyst target.
- Consumer/deposit franchise ($2T deposits, normalized credit) cushions the downside, limiting how far BAC can fall if Q3 IB misses cleanly.
- Q2 IB fees of $1.55B (+44%) and ECM up 91% in H1 show Citi participates in the boom — but stock fell 5.3% post-print on expense worries, signaling weak narrative support.
- Sits between JPM and BAC: enough capital-markets exposure to feel a slowdown, enough international book (which Moynihan flagged as weak) to be hurt disproportionately.
- Short-term: watch whether Citi guides a BofA-style Q3 slowdown or holds the JPM-style bullish line when it reports in mid-October.
- Q2 IB fees of $3.4B (+55% YoY) make GS the highest-beta name to a JPM-style Q3 \"shine\" — or the largest single beneficiary if the cycle rolls over BofA-style.
- Pure-play exposure to capital markets means GS is the cleanest single-name read on whether Petno or Moynihan is right about Q3 industry direction.
- Catalyst pending: GS Q3 earnings in mid-October; if it confirms JPM's mid-to-high teens trading view, the whole cohort re-rates higher.
- Q2 net income of $5.58B and revenue of $34.5B are supported by a heavier wealth-and-asset-management mix, less cyclical than JPM/BAC capital-markets lines.
- Capital-markets arm still cycles with the group, so a BofA-style IB slowdown still drags EPS — but the wealth franchise cushions the hit.
- Best positioned among US banks for a \"capital markets slow, everything else fine\" scenario — but limited upside if JPM's bullish view plays out.
- Least exposure to IB and trading revenue of the major US banks; Q2 beat was NII-and-credit driven, not capital-markets driven.
- Insulates WFC from a BofA-style drawdown if capital markets slow, but limits the upside if JPM's Q3 \"shine\" thesis plays out across the group.
- Catalyst pending: Q3 earnings in mid-October will test whether NII growth (deposit franchise, asset-quality normalization) carries the stock through a quiet capital-markets quarter.
